Form 4: Solen Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
A Soleno Therapeutics executive sold shares to cover tax obligations related to vesting restricted stock units.
Summary
- Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold a total of 4,860 shares of common stock across three transactions.
- The sales occurred on January 2nd and 3rd, 2025.
- The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- The weighted average sale prices ranged from $45.3656 to $46.1764 per share.
- After these transactions, Ms. Yen directly owns 76,605 shares of Soleno Therapeutics common stock, some of which are RSUs.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction for an executive, with no indication of positive or negative sentiment. It is a neutral event.
Industry Context
This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.
Comparison to Industry Standards
- Executive stock sales to cover tax obligations are a common practice across the industry.
- The sale prices are within the typical range for stock transactions of this nature.
- Similar transactions are regularly reported by executives at comparable biotech companies.
Stakeholder Impact
- The stock sales may have a minor impact on the stock price, but are unlikely to significantly affect shareholders.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Kristen Yen sold 2,322 shares at a weighted average price of $45.3656 and 198 shares at a weighted average price of $45.92. |
| 01/03/2025 | Kristen Yen sold 2,340 shares at a weighted average price of $46.1764. |
| 01/06/2025 | Date of signature for the SEC Form 4 filing. |
Keywords
insider trading, stock sale, restricted stock units, tax obligations, Solen Therapeutics, SLNO, executive
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.